News

Hair Botox In India: Safety, Efficacy, And Who Should (Or Should Not) Use It
Hair botox is gaining popularity in India as a chemical free alternative to keratin treatments for frizzy or damaged hair.
Endovascular Today1d
Philips UroNav System for Prostate Cancer Treatment Cleared by FDA
Royal Philips recently announced FDA 510(k) clearance of the latest version of the company’s UroNav system for image-guided ...
New NHS fat jab guidance issued as top doctor says it's 'crucial'
The updated standard replaces three previous guidelines and reflects the latest thinking on tackling obesity through the ...
NHS makes weight loss jab guidance change including Wegovy and Mounjaro - 'it's crucial'
People using weight loss medication have been told it's not a "quick fix" with many at risk of regaining their lost weight.
NHS fat jab medication guidance change including Wegovy and Mounjaro - 'it's crucial'
People using weight loss medication have been warned it is not a "quick fix" with many at risk of regaining their lost weight ...
New Drug May Fight a Deadly Bone Marrow Disorder
By Dennis Thompson HealthDay ReporterTUESDAY, Aug. 5, 2025 (HealthDay News) — A recently approved leukemia pill also might ...
Stop children getting trans drugs from private clinics, Streeting told
High Court ruling creates a ‘two-tier system’ in gender healthcare for under-18s, former Tavistock nurse warns ...
As more young people get screened, more colon cancer is being found early. Here’s how to lower your risk
Even more colorectal cancer cases are being found in adults under 50, and a new collection of research suggests that a surge ...
ICON Plc’s Earnings Call: Balancing Achievements and Challenges
The recent earnings call for ICON Plc presented a balanced perspective on the company’s performance. While there were notable achievements in business awards, cost management, and strategic ...
FDA Approves Apellis’ EMPAVELI® (pegcetacoplan) as the First C3G and Primary IC-MPGN Treatment for Patients 12 and Older
(Nasdaq: APLS) today announced that the U.S. Food and Drug Administration (FDA) has approved EMPAVELI ® (pegcetacoplan) as ...